This content is exclusively provided by FAO / FAOLEX

One Health Master Action Plan for Australia’s National Antimicrobial Resistance Strategy 2020 & Beyond

Country
Type of law
Policy
Source

Abstract
The One Health Master Action Plan for Australia’s National Antimicrobial Resistance Strategy 2020 & Beyond is a national cross-sectoral plan of Australia. Its main objectives are to create sustainable funding for combatting antimicrobial resistance based on evidence of economic and societal costs and benefits of different approaches in all sectors; to develop, implement and/or maintain sector-specific action plans; to maintain and expand linkages and opportunities between stakeholders across all sectors to provide a nationally coordinated approach to combatting antimicrobial resistance; to monitor and review regulatory measures (legislated and other) relevant to antimicrobial usage and resistance ; to adopt evidence-based and nationally consistent standards for infection prevention and control and biosecurity; to maximise compliance with best practice infection prevention and control and biosecurity measures through adherence to applicable legislation, targets and accreditation standards; to promote disease prevention practices to reduce infections and subsequent use of antimicrobials; to share information on emerging antimicrobial resistance trends to inform responses; to develop and implement a coordinated, One Health communication strategy, as well as monitoring and evaluation, to support whole-of-society awareness and behavioural change; to strengthen public and political awareness to champion and improve the understanding of combatting antimicrobial resistance ; to create new and different key antimicrobial resistance messages that resonate with society; to drive education and training initiatives across all relevant sectors and increase accessibility to evidence-based best-practice information; Ensure that coordinated, evidence-based antimicrobial prescribing guidelines and best-practice supports are developed and made easily available, and encourage their use by prescribers; to develop and implement effective mechanisms to monitor, reward and enforce compliance with standards and best-practice approaches for appropriate and judicious antimicrobial use; to use data on antimicrobial usage to inform antimicrobial stewardship policy and support the development of targeted, timely and effective responses; to create a sustainably funded national One Health surveillance system that integrates human, animal, food and environmental usage and resistance data; to develop and regularly review lists of priority organisms and associated antimicrobials ; national alignment of laboratory testing practices and reporting for antimicrobial resistance; to use evidence-based surveillance and monitoring data to inform actions and responses to contain antimicrobial resistance; to set a flexible national antimicrobial resistance research and development agenda that strives for innovation; to coordinate and share research and development activities; Seek and maintain dedicated funding for the national research and development agenda, including private and public investment partnerships; to support the translation of research findings into new approaches, applications and policies to combat antimicrobial resistance; to influence the global antimicrobial resistance agenda by active engagement and collaboration with other countries, multilateral organisations and forums; to promote the importance of antimicrobial resistance in the South East Asia and Pacific regions, and engage in related initiatives to build regulatory and other capacity; and to participate in international surveillance and monitoring initiatives.
Date of text
Entry into force notes
2020 and Beyond
Repealed
No
Source language

English

Legislation Amendment
No